Intraamniotic Candida infection is uncommon but the consequence can be catastrophic. Transcer vical amphotericin B and intraamniotic fluconazole administration were identified in the literature. We present a case with intact membranes and ongoing pregnancy treated by maternal intravenous liposomal amphotericin B. A primipara who underwent cerclage placement before fetal viability was diagnosed with intraamniotic Candida infection. Although maternal intravenous liposomal amphotericin B eradicated fungi in the amniotic cavity, Escherichia coli invasion caused devastating chorioamnionitis. The newborn delivered at 27 +3 weeks' gestation did not survive due to respiratory distress syndrome and sepsis. Despite negative conversion of intraamniotic culture results for fungi after treatment, another pathogen such as bacteria could ascend into the amniotic cavity via weak ened membranes. Clinicians should consider broadspectrum antibiotics as well as antifungal agents in this setting.
Introduction
Compared with frequent vaginal candidiasis in pregnancy, intra-amniotic Candida infection is relatively uncommon and occupied 2.2−6.5% among patients with positive amnio tic fluid culture results and preterm labor or preterm premature rupture of membranes. 1 Some authors reported that intra-amniotic Candida infection was commonly associated with retained foreign body (e.g., intrauterine contraceptive device and cerclage placement) in the uterine or vaginal cavity. 1, 2 However, the consequence of it can be catastrophic. It has been reported to cause from skin diseases to mortalities or significant morbidities such as congenital pneumonia, respiratory distress syndrome, broncho-pul monary dy splasia, sepsis, or cerebral candidiasis. 1 Because of this fatality and paucity of effective treatment modalities in pregnancy, a majority of experts and clinicians have recommended prompt delivery. Therefore, the diagnosis of intra-amniotic Candida infection during previable periods presents a therapeu tic dilemma for attending physicians. Until now, there were only three cases report ed by two authors which presented maternal or intra-amniotic antifungal agents therapy to ongoing pregnant women who were diagnosed with intra-amniotic Candida infec tion proved by transabdominal amniocentesis. 3, 4 We present the first case of intra-amniotic Candida infection which underwent emergent cervical cerclage due to cervical incom petence and was treated with maternal intravenous liposomal amphotericin B. 9 Although it is relevant to higher dose and longer duration therapy in the early first trimester, it is considered that use of oral azole antifungal agents should be limited to cases of maternal life-threatening infection.
Intra-Amniotic
Another point is that the newborn died from E. coli sepsis despite eradication of intra-amniotic fungi. The patient had complained of loose stool several times about a week before delivery. This might result in vaginal contamination by feces and enabling colonic bacteria to ascend into amniotic cavity via weakened fetal membranes.
In conclusion, single therapy of maternal intravenous liposomal amphotericin B is safe and effective to eliminate Candida albicans in the amniotic cavity. Despite negative conver sion of intra-amniotic culture results for fungi during antifun gal agents therapy, another pathogens such as bacteria could ascend into the amniotic cavity via weakened fetal membranes. Therefore, clinicians should consider broad-spectrum antibio tics as well as antifungal agents in treatment of intra-amniotic Candida infection.
stopped and the patient at 25 +0 weeks' gestation was discharged on hospital day 25. After discharge, weekly follow-up at our outpatient's clinic was conducted.
During the follow-up periods, she was asymptomatic but had increased vaginal discharge and frequent loose stool three to four times a day. A sterile speculum examination re- 
Discussion
Although vaginal colonization of Candida species occurs in approximately 25% of pregnancy, the incidence of ascending infection is very low. 1 Intra-amniotic Candida infection is frequently associated with retained intrauterine device or cerclage placement. 1, 2, 4 In the case presented in this report, it is considered that protruding fetal membranes due to cervical insufficiency might be a predisposing factor for ascending intrauterine fungal infection.
According to reported data from conventional amphotericin B use during pregnancy, cord blood and placenta level of amphotericin B remained within the minimum inhibitory concentration ranges for up to 4 weeks after the last dose of the drug. 6 Although the exact mode of elimination of amphotericin B remains to be clarified, the researchers suggested that the agent accumulates in tissues that then acts as a reservoir from which amphotericin B is slowly released back into circulation.
